难治性强迫症的脑深部刺激:新兴还是成熟疗法?
本文基于世界立体定向与功能神经外科学会(WSSFN)2014年共识标准,汇总已发表证据以判断脑深部刺激(DBS)治疗难治性强迫症(OCD)是否已成为成熟疗法。两项盲法随机对照试验分别报告Y-BOCS评分改善37%(I级证据)和25%(II级证据),临床队列研究(N=70)和前瞻性国际多中心研究(N=30)分别报告40%和42%改善。WSSFN声明该疗法仍属研究性、新兴但尚未成熟,多学科团队是前提。
要点
- 两项盲法随机对照试验报告Y-BOCS评分改善37%和25%,达到WSSFN成熟疗法标准中关于随机对照试验的要求。
- 临床队列研究(N=70)和前瞻性国际多中心研究(N=30)分别报告Y-BOCS评分改善40%和42%。
- WSSFN认定DBS治疗难治性OCD仍属研究性、新兴但尚未成熟的疗法,多学科团队是必要条件。
核心结论
- 脑深部刺激治疗难治性强迫症是新兴但尚未成熟的疗法。
研究设计与样本
- 本文汇总已发表证据,依据WSSFN 2014年共识标准评估DBS治疗难治性OCD是否成为成熟疗法。
主要发现
- 一项盲法随机对照试验(I级证据)报告刺激开启时Y-BOCS评分改善37%。
- 另一项盲法随机对照试验(II级证据)报告Y-BOCS评分改善25%。
- 一项临床队列研究(N=70)显示DBS期间Y-BOCS评分改善40%。
- 一项前瞻性国际多中心研究(N=30)报告Y-BOCS评分改善42%。
关键数值与推荐
- WSSFN 2014年共识标准:至少两项来自不同研究组的盲法随机对照临床试验发表,均报告可接受的风险获益比且至少与其他现有疗法相当,试验应针对同一脑区同一精神科适应症。
- WSSFN声明:使用多极电极植入腹前囊区(包括终纹床核和伏隔核)的电刺激治疗其他方法难治的OCD仍属研究性。
临床怎么用
- DBS治疗难治性OCD需要精神科医生和神经外科医生参与的多学科团队。
- 精神科患者的外科治疗未来仍应属于精神科医生的领域。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A consensus has yet to emerge whether deep brain stimulation (DBS) for treatment-refractory obsessive-compulsive disorder (OCD) can be considered an established therapy. In 2014, the World Society for Stereotactic and Functional Neurosurgery (WSSFN) published consensus guidelines stating that a therapy becomes established when "at least two blinded randomized controlled clinical trials from two different groups of researchers are published, both reporting an acceptable risk-benefit ratio, at least comparable with other existing therapies. The clinical trials should be on the same brain area for the same psychiatric indication." The authors have now compiled the available evidence to make a clear statement on whether DBS for OCD is established therapy. Two blinded randomized controlled trials have been published, one with level I evidence (Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score improved 37% during stimulation on), the other with level II evidence (25% improvement). A clinical cohort study (N = 70) showed 40% Y-BOCS score improvement during DBS, and a prospective international multi-center study 42% improvement (N = 30). The WSSFN states that electrical stimulation for otherwise treatment refractory OCD using a multipolar electrode implanted in the ventral anterior capsule region (including bed nucleus of stria terminalis and nucleus accumbens) remains investigational. It represents an emerging, but not yet established therapy. A multidisciplinary team involving psychiatrists and neurosurgeons is a prerequisite for such therapy, and the future of surgical treatment of psychiatric patients remains in the realm of the psychiatrist.
引用
- Wu H, Hariz M, Visser-Vandewalle V, et al. Deep brain stimulation for refractory obsessive-compulsive disorder (OCD): emerging or established therapy? Mol Psychiatry. 2020. PMID: 33144712. doi:10.1038/s41380-020-00933-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。